CCL
67
2
INTC
49
-3
STT
50
5
PG
37
2
CVS
58
-2
DE
56
3
NEE
54
-11
HSIC
45
-2
AVGO
40
-2
HRL
33
3
IPG
53
6
MA
43
2
FSLR
44
-6
PM
52
2
ED
45
3
NOV
40
-2
NRG
55
-4
K
45
3
F
40
-6
HES
54
-2
CCL
67
2
INTC
49
-3
STT
50
5
PG
37
2
CVS
58
-2
DE
56
3
NEE
54
-11
HSIC
45
-2
AVGO
40
-2
HRL
33
3
IPG
53
6
MA
43
2
FSLR
44
-6
PM
52
2
ED
45
3
NOV
40
-2
NRG
55
-4
K
45
3
F
40
-6
HES
54
-2
Financhill
Back

Xenon Pharmaceuticals Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
16

XENE
Xenon Pharmaceuticals

Last Price:
$32.11
Seasonality Move:
7.25%

7 Day Trial

ALL ACCESS PASS

$ 7

Xenon Pharmaceuticals Stock Forecast

  • Over the next 52 weeks, Xenon Pharmaceuticals has on average historically risen by 26.6% based on the past 10 years of stock performance.
  • Xenon Pharmaceuticals has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Xenon Pharmaceuticals Stock Undervalued?
    The current Xenon Pharmaceuticals [XENE] share price is $31.62. The Score for XENE is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • XENE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Xenon Pharmaceuticals Stock Go Up Next Year?

  • Over the next 52 weeks, Xenon Pharmaceuticals has on average historically risen by 26.6% based on the past 10 years of stock performance.

Xenon Pharmaceuticals Stock Rating

Sell
16
Xenon Pharmaceuticals (XENE) is a Sell

Is Xenon Pharmaceuticals overpriced?

  • Xenon Pharmaceuticals has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Xenon Pharmaceuticals Stock Price History

Is XENE stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XENE is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Canada
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
xenon-pharma.com

52-Week Data

52-Week High:
46.00
52-Week Low:
26.74

Prediction Charts

Market Cap:
2.4B
Price in USD:
31.62
Volume:
938.6K
Beta:
1.22

Technical Analysis

SMA50:
31.84
SMA100:
33.56
SMA200:
37.12
52-Wk Change:
-26.36%

Stock Predictions

  • Is Xenon Pharmaceuticals stock public?
    Yes, Xenon Pharmaceuticals is a publicly traded company.
  • What is the Xenon Pharmaceuticals stock quote today?
    The Xenon Pharmaceuticals stock price is 31.62 USD today.
  • How to buy Xenon Pharmaceuticals stock online?
    You can buy Xenon Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-26 31.72 32.20 32.23 31.34
Jun-27 32.35 32.40 32.99 32.00
Jun-30 32.32 31.30 32.57 31.16
Jul-1 31.16 32.09 32.53 31.09
Jul-2 31.97 33.37 33.44 31.90
Jul-3 33.70 33.26 33.83 33.06
Jul-7 32.69 31.83 33.12 31.64
Jul-8 31.83 31.42 32.24 31.22
Jul-9 31.68 32.68 33.51 31.65
Jul-10 32.60 32.98 33.36 32.09
Jul-11 32.79 32.21 33.15 32.10
Jul-14 32.21 32.60 33.23 32.20
Jul-15 32.79 31.48 32.79 31.40
Jul-16 31.49 31.62 32.10 31.15

Xenon Pharmaceuticals Earnings

Xenon Pharmaceuticals Earnings Report: Per Share Xenon Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

Xenon Pharmaceuticals Forecast Revenue Growth

Xenon Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Xenon Pharmaceuticals and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.02 per share, a decrease this year of $0.93 per share, and a decrease next year of $0.33 per share.

* Xenon Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.